Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130256014M |
| Application |
Cardiac Marker |
The kit has been designed for the quantitative determination of Troponin I (high sensitive) in human serum. The method can be used for samples over the range of 0-50ng/ml. The test has to be performed on the MAGLUMI chemiluminescence immunoassay (CLIA) fully auto analyzer (Including MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus and new developed models).Reliable Chemiluminescence Immunoassay TechnologyUtilizing advanced chemiluminescence immunoassay (CLIA) technology, MAGLUMI hs-cTnI reagents provide highly sensitive and precise cardiac biomarker measurements. This technology enables enhanced detection capabilities, making it invaluable for clinical laboratories aiming for accurate and timely results.
Designed for MAGLUMI CLIA AnalyzersThese reagents are exclusively tailored for use with MAGLUMI branded CLIA analyzers, ensuring a seamless integration into existing laboratory workflows. This compatibility optimizes performance and delivers consistently reliable outcomes for cardiac troponin I testing.
Strict Storage Guidelines for Optimal PerformanceTo maintain integrity and efficacy, MAGLUMI hs-cTnI reagents should be stored at temperatures between 2 and 8C. Proper storage helps preserve the reagents' stability, guaranteeing accurate results throughout their shelf life.
FAQ's of MAGLUMI hs-cTnl I (CLIA):
Q: How is the MAGLUMI hs-cTnI (CLIA) reagent used in a laboratory setting?
A: The MAGLUMI hs-cTnI (CLIA) reagent is employed with MAGLUMI CLIA analyzers in laboratories to quantitatively determine cardiac troponin I levels, facilitating the diagnosis and monitoring of cardiac events in real-time.
Q: What is the process for running a test with this reagent kit?
A: Simply load the MAGLUMI hs-cTnI reagent onto a compatible MAGLUMI CLIA analyzer, follow the instrument's instructions for the cardiac troponin I assay, and the system will automatically run and report results with high sensitivity.
Q: When should the hs-cTnI test be performed using these reagents?
A: This test is typically conducted when a patient shows symptoms of acute coronary syndromes or when a physician needs to assess potential cardiac injury, enabling prompt and informed clinical decisions.
Q: Where can laboratories acquire this product in India?
A: MAGLUMI hs-cTnI reagents are available through multiple channels such as authorized dealers, distributors, manufacturers, and wholesalers throughout India.
Q: What are the storage requirements for maintaining reagent quality?
A: To ensure reagent stability and reliability, it is essential to store the MAGLUMI hs-cTnI kit between 2 and 8 degrees Celsius, away from light and excessive heat.
Q: How does chemiluminescence immunoassay technology benefit cardiac diagnosis?
A: CLIA technology in this reagent allows for extremely sensitive detection of troponin I, supporting faster and more accurate identification of cardiac events, which is critical for patient management and outcomes.